Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-I”

2,536 trials

Showing 20 of 2,536 results

Testing effectiveness (Phase 2)Study completedNCT00001132
What this trial is testing

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Large-scale testing (Phase 3)Study completedNCT00144287
What this trial is testing

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

Who this might be right for
HIV Infections
Boehringer Ingelheim 255
Post-approval studies (Phase 4)Looking for participantsNCT04553081
What this trial is testing

2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial

Who this might be right for
HIV-1-infection
University Hospital, Ghent 134
Early research (Phase 1)Study completedNCT00002250
What this trial is testing

A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura ( ITP )HIV Infections
Genentech, Inc.
Early research (Phase 1)Study completedNCT00000630
What this trial is testing

Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 35
Large-scale testing (Phase 3)Study completedNCT00323544
What this trial is testing

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

Who this might be right for
HIV Infections
Gilead Sciences 220
Early research (Phase 1)Study completedNCT00854204
What this trial is testing

Innovation-TiFP4-C101: A Study to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629

Who this might be right for
HIV-I
Tibotec Pharmaceuticals, Ireland 12
Testing effectiveness (Phase 2)Study completedNCT02412436
What this trial is testing

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Who this might be right for
HIV-1 InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 62
Testing effectiveness (Phase 2)WithdrawnNCT05130086
What this trial is testing

Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infections
Merck Sharp & Dohme LLC
Early research (Phase 1)Study completedNCT03803605
What this trial is testing

Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons

Who this might be right for
HIV-1 Infection
University of North Carolina, Chapel Hill 15
Not applicableStudy completedNCT03500172
What this trial is testing

HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)

Who this might be right for
HIV-1 Virologic Response
Johns Hopkins Bloomberg School of Public Health 1,391
Early research (Phase 1)Study completedNCT01101893
What this trial is testing

A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 15
Early research (Phase 1)Study completedNCT01103687
What this trial is testing

Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT02818348
What this trial is testing

Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected Patients

Who this might be right for
HIV-1 Infection
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 30
Large-scale testing (Phase 3)Study completedNCT02483078
What this trial is testing

Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140

Who this might be right for
HIV
CytoDyn, Inc. 52
Large-scale testing (Phase 3)Looking for participantsNCT07044297
What this trial is testing

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Who this might be right for
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC 4,390
Early research (Phase 1)Study completedNCT02411435
What this trial is testing

Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 15
Early research (Phase 1)Study completedNCT00000738
What this trial is testing

Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1

Who this might be right for
AIDS Dementia ComplexHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06626555
What this trial is testing

Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection

Who this might be right for
HIV
University College, London 36
Early research (Phase 1)Active Not RecruitingNCT05612178
What this trial is testing

Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy

Who this might be right for
HIV-1
National Institute of Allergy and Infectious Diseases (NIAID) 105
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation